Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)
Study sponsor: Pliant Therapeutics, Inc. · PLRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-12-27Actual
Enrollment · participants10Actual
Source updated2025-12-05Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.